Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernd Schmidt

Showing results (121-130 of 146) with videos related to

Pageof 15
Sort By:
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|May 4, 2023
Impact of Coronavirus Disease 2019 on Hospital Admissions, Health Status, and Behavioral Changes of Patients with COPDEva Pappe, Ralf Hammerich, Jacopo Saccomanno, et al.
Antioxidants (Basel, Switzerland)|December 30, 2025
Ovatifolin Purified from <i>Leptocarpha rivularis</i> Induces Cell Death in A375 and A2058 Melanoma Cancer CellsViviana Burgos, Nicole Cortez, Rocío Aguilera-Paillán, et al.
Current Oncology (Toronto, Ont.)|December 24, 2025
Independent Validation of a Machine Learning Classifier for Predicting Mediastinal Lymph Node Metastases in Non-Small Cell Lung Cancer Using Routinely Obtainable [<sup>18</sup>F]FDG-PET/CT ParametersAgata Wdowiak, Julian M M Rogasch, Georg L Baumgärtner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 23, 2023
A machine learning tool to improve prediction of mediastinal lymph node metastases in non-small cell lung cancer using routinely obtainable [<sup>18</sup>F]FDG-PET/CT parametersJulian M M Rogasch, Liza Michaels, Georg L Baumgärtner, et al.
Frontiers in Pharmacology|March 14, 2024
<i>In vitro</i> and <i>in silico</i> studies reveal antidiabetic properties of arylbenzofurans from the root bark of <i>Morus mesozygia</i> StapfKatherine Olabanjo Olufolabo, Kai Lüersen, Samuel Ayoolu Oguntimehin, et al.
Thorax|November 13, 2025
Sex differences in outcome after endoscopic lung volume reduction (ELVR) in patients with emphysema: a retrospective analysis of the German Lung Emphysema Registry (LER e.V.)Elvin Atug, Franziska Christina Trudzinski, Angélique Holland, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 31, 2010
Complement factor H is elevated in bronchoalveolar lavage fluid and sputum from patients with lung cancerRuben Pio, Javier Garcia, Leticia Corrales, et al.
BMC Cancer|March 24, 2011
Correlation of SHOX2 gene amplification and DNA methylation in lung cancer tumorsKatja U Schneider, Dimo Dietrich, Michael Fleischhacker, et al.
International Journal of Oncology|November 24, 2011
Performance evaluation of the DNA methylation biomarker SHOX2 for the aid in diagnosis of lung cancer based on the analysis of bronchial aspiratesDimo Dietrich, Christoph Kneip, Olaide Raji, et al.
Plos One|March 24, 2015
Elevated levels of the complement activation product C4d in bronchial fluids for the diagnosis of lung cancerDaniel Ajona, Cristina Razquin, Maria Dolores Pastor, et al.
Pageof 15

Showing results (121-130 of 146) with videos related to

Sort By:
Pageof 15
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|May 4, 2023
Impact of Coronavirus Disease 2019 on Hospital Admissions, Health Status, and Behavioral Changes of Patients with COPDEva Pappe, Ralf Hammerich, Jacopo Saccomanno, et al.
Antioxidants (Basel, Switzerland)|December 30, 2025
Ovatifolin Purified from <i>Leptocarpha rivularis</i> Induces Cell Death in A375 and A2058 Melanoma Cancer CellsViviana Burgos, Nicole Cortez, Rocío Aguilera-Paillán, et al.
Current Oncology (Toronto, Ont.)|December 24, 2025
Independent Validation of a Machine Learning Classifier for Predicting Mediastinal Lymph Node Metastases in Non-Small Cell Lung Cancer Using Routinely Obtainable [<sup>18</sup>F]FDG-PET/CT ParametersAgata Wdowiak, Julian M M Rogasch, Georg L Baumgärtner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 23, 2023
A machine learning tool to improve prediction of mediastinal lymph node metastases in non-small cell lung cancer using routinely obtainable [<sup>18</sup>F]FDG-PET/CT parametersJulian M M Rogasch, Liza Michaels, Georg L Baumgärtner, et al.
Frontiers in Pharmacology|March 14, 2024
<i>In vitro</i> and <i>in silico</i> studies reveal antidiabetic properties of arylbenzofurans from the root bark of <i>Morus mesozygia</i> StapfKatherine Olabanjo Olufolabo, Kai Lüersen, Samuel Ayoolu Oguntimehin, et al.
Thorax|November 13, 2025
Sex differences in outcome after endoscopic lung volume reduction (ELVR) in patients with emphysema: a retrospective analysis of the German Lung Emphysema Registry (LER e.V.)Elvin Atug, Franziska Christina Trudzinski, Angélique Holland, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 31, 2010
Complement factor H is elevated in bronchoalveolar lavage fluid and sputum from patients with lung cancerRuben Pio, Javier Garcia, Leticia Corrales, et al.
BMC Cancer|March 24, 2011
Correlation of SHOX2 gene amplification and DNA methylation in lung cancer tumorsKatja U Schneider, Dimo Dietrich, Michael Fleischhacker, et al.
International Journal of Oncology|November 24, 2011
Performance evaluation of the DNA methylation biomarker SHOX2 for the aid in diagnosis of lung cancer based on the analysis of bronchial aspiratesDimo Dietrich, Christoph Kneip, Olaide Raji, et al.
Plos One|March 24, 2015
Elevated levels of the complement activation product C4d in bronchial fluids for the diagnosis of lung cancerDaniel Ajona, Cristina Razquin, Maria Dolores Pastor, et al.
Pageof 15